Nanobiotix reports proof of concept for brain cancer treatment

April 6, 2009 Emerging nanomedicine company Nanobiotix says that an independent preclinical study has validated the applicability of using its “nanoPDT” nanoparticles to treat glioblastoma multiforme, one of the most prevalent brain tumors. Nanobiotix expects to attract corporate partners for the development of nanoPDT as the company focuses development efforts on its nanoXray technology, the firm said in a news release.

Co-funded by Nanobiotix and Cancéropôle Lyon Auvergne Rhône-Alpes (‘CLARA’), the proof-of-concept preclinical study was conducted by the French National Institute for Health and Medical Research (INSERM) under principal investigator and neuro-oncologist Jérôme Honnorat.

“Our nanotechnology is designed to allow for the precise destruction of cancer cells via the controlled application of an outside-the-body energy source — in this case, a laser beam. Of course, there is much more work to be done, but we are extremely encouraged by these preclinical findings, which dramatically demonstrate the therapeutic effect of nanoparticles on glioblastoma and open the possibility of a new weapon with which neuro-oncologists might fight this difficult-to-treat tumor,” said Laurent Lévy, Ph.D., president and CEO of Nanobiotix and co-president of the French Technology Platform on Nanotechnology (FTPN).

“The nanoPDT particles allow for the controlled generation of physical reactions in targeted cells when triggered by the application of an external energy source — a laser beam in this case. This may have significant ramifications for cancer therapy in the not-too-distant future,” added Paras N. Prasad, one of the inventors of the Nanobiotix technology.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

LIVE NEWS FEED

NEW PRODUCTS

OEM Group expands P5000 capabilities to compound semiconductor substrates
05/25/2017OEM Group has launched the P5000:CS automated single wafer cluster tool for the compound semiconductor market. ...
3D-Micromac launches the second generation of its high-performance microcell OTF laser systems
04/17/2017The high-performance production solution for Laser Contact Opening (LCO) of PERC solar cells achieves a th...
ULVAC launches NA-1500 dry etching system for 600mm advanced packaging systems
03/24/2017ULVAC, Inc. is pleased to announce the NA-1500 dry etching system for 600mm advanced packaging substrates, providing for u...